Company
BIOCRYST PHARMACEUTICALS INC
BCRX · CIK 0000882796
STOCK ACT PTR
$1,001 - $15,000
Purchase.
Filer Gilbert Cisneros · Chamber House · District CA31 · Transaction Type Purchase · Asset Type Stock
Traded Jul 10, 2026 · Disclosed Sep 4, 2026FILED +56 DAYS
Source: House Clerk PTR · 20035190 · filed 2026-09-04 · View filing →
STOCK ACT PTR
$1,001 - $15,000
Purchase.
Filer Gilbert Ray Cisneros · Chamber House · District CA31 · Transaction Type Purchase · Asset Type Stock
Traded Jul 9, 2026 · Disclosed Sep 4, 2026FILED +57 DAYS
Source: House Clerk PTR · 20035190 · filed 2026-09-04 · View filing →
Acquisition (code A) of 1,288 shares at $9.70 per share.
Reporting Person Frank Steven · Transaction Code A
Traded Aug 31, 2026 · Disclosed Sep 2, 2026
Source: SEC Form 4 · 0000882796-26-000057 · filed 2026-09-02 · View filing →
Acquisition (code A) of 644 shares at $9.70 per share.
Reporting Person McKee Amy E · Transaction Code A
Traded Aug 31, 2026 · Disclosed Sep 2, 2026
Source: SEC Form 4 · 0000882796-26-000059 · filed 2026-09-02 · View filing →
Acquisition (code A) of 1,159 shares at $9.70 per share.
Reporting Person MILANO VINCENT · Transaction Code A
Traded Aug 31, 2026 · Disclosed Sep 2, 2026
Source: SEC Form 4 · 0000882796-26-000061 · filed 2026-09-02 · View filing →
Acquisition (code A) of 1,288 shares at $9.70 per share.
Reporting Person Milne Jill C. · Transaction Code A
Traded Aug 31, 2026 · Disclosed Sep 2, 2026
Source: SEC Form 4 · 0000882796-26-000063 · filed 2026-09-02 · View filing →
Acquisition (code A) of 644 shares at $9.70 per share.
Reporting Person Stonehouse Jon P · Transaction Code A
Traded Aug 31, 2026 · Disclosed Sep 2, 2026
Source: SEC Form 4 · 0000882796-26-000065 · filed 2026-09-02 · View filing →